Kewaunee Scientific Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2023
For the full year, sales was USD 219.49 million compared to USD 168.87 million a year ago. Net income was USD 0.738 million compared to net loss of USD 6.13 million a year ago. Basic earnings per share from continuing operations was USD 0.26 compared to basic loss per share from continuing operations of USD 2.2 a year ago. Diluted earnings per share from continuing operations was USD 0.25 compared to diluted loss per share from continuing operations of USD 2.2 a year ago.